Back To: Home : Featured Technology : High Throughput Screening

CLICK HERE FOR WHAT'S NEW IN:
 

BellBrook Labs gains patent for novel drug discovery platform
July 2008
SHARING OPTIONS:

MADISON, Wis.BellBrook Labs, a provider of high throughput screening tools for the drug discovery industry, announced that the U.S. Patent and Trademark Office has approved the issuance of two patents to the company for the Transcreener HTS Assay platform. These are the second and third patents to issue in a series of allowed patents covering the Transcreener technology.

 "No other technology platform allows screening of so many targets, both well characterized and emerging, as Transcreener" says Bob Lowery, CEO of BellBrook.  "The strength of the technology has resulted in widespread adoption in large-scale compound screens among the top pharmaceutical and biotechnology companies around the world."
 

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.